J Korean Soc Radiol.
2022 Mar;83(2):254-264. 10.3348/jksr.2022.0024.
Korean Clinical Practice Guidelines for Adverse Reactions to Intravenous Iodinate and MRI-Gadolinium Contrast Agents: Revised Clinical Consensus and Recommendations (3rd Edition, 2022)
- Oh SW
1 - Park SY2
- Yong HS3
- Choi YH4
- Cha MJ5
- Kim TB6
- Lee JH6
- Kim SH7
- Lee JH8
- Hur GY9
- Hwang JY10
- Kim S11
- Kim HS12
- Ryu JY13
- Choi M14
- Choi CH15
- Affiliations
-
- 1Department of Radiology, The Catholic University of Korea, Eunpyeong St. Mary’s Hospital, Seoul, Korea
- 2Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
- 3Department of Radiology, Cardiothoracic Division, Korea University Guro Hospital, Seoul, Korea
- 4Department of Radiology, Seoul National University Hospital, Seoul, Korea
- 5Department of Radiology, Chung-Ang University College of Medicine, Seoul, Korea
- 6Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 7Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
- 8Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- 9Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- 10Department of Radiology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, College of Medicine, Pusan National University, Yangsan, Korea
- 11Division of Nephrology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
- 12Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea
- 13Division of Nephrology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea
- 14Division of Health Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea
- 15Department of Radiology, Chungbuk National University Hospital, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea
- KMID: 2527787
- DOI: http://doi.org/10.3348/jksr.2022.0024
Abstract
- The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the “Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition).” Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Acute Adverse Reactions to Gadolinium-based Intravenous Contrast Agents for MRI : Retrospective Analysis Using Computed Reporting System
- Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology
- 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
- Guidelines for the Treatment of Osteoarthritis of the Knee
- Clinical experience of adverse drug reaction in gadolinium-DTPA enhancement of MRI
